For treatments with fairly significant benefits, regulators can approve modest trial sizes, such as Randomized trials with at least 42 participating patients redetected statistically significant 100 % improvements in outcome measures with α=0.05 and β=0.1 [ 196 ].
← all excerpts
Regenerative rehabilitation: a novel multidisciplinary field to maximize patient outcomes.
1
—
—